Mozhgan Dorkhan
16 – 24 of 24
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2010
-
Mark
Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes.
(
- Contribution to journal › Article
- 2009
-
Mark
Effect of pioglitazone versus insulin glargine on cardiac size, function, and measures of fluid retention in patients with type 2 diabetes
(
- Contribution to journal › Article
- 2008
-
Mark
Treatment with pioglitazone induced significant, reversible mitral regurgitation
(
- Contribution to journal › Article
-
Mark
Assessment and Treatment of Impaired Insulin- Secretion and Action in Type 2 Diabetes
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Differences in effects of insulin glargine or pioglitazone added to oral anti-diabetic therapy in patients with type 2 diabetes What to add-Insulin glargine or pioglitazone?
(
- Contribution to journal › Article
-
Mark
Independent measures of insulin secretion and insulin sensitivity during the same test: the glucagon-insulin tolerance test.
(
- Contribution to journal › Article
- 2007
-
Mark
A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes.
(
- Contribution to journal › Scientific review
- 2006
-
Mark
Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Glycemic and non-glycemic effects of pioglitazone in triple oral therapy in patients with type 2 diabetes mellitus
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »